FDA lifts partial clinical hold on Rezolute's low blood sugar treatment

Rezolute Inc (RZLT.O)said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study testing the company's treatment for low blood sugar, sending its shares up 10.3% in early trading.